Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases

被引：0
|
作者：
Marc Humbert
Gérald Simonneau
机构：
[1] Professors of Respiratory Medicine at the Center for Pulmonary Vascular Diseases,
[2] Service de Pneumologie et Réanimation Respiratoire,undefined
[3] Hôpital Antoine Béclère,undefined
[4] Assistance-Publique Hôpitaux de Paris,undefined
[5] Université Paris-Sud,undefined
来源：
Nature Clinical Practice Rheumatology | 2005年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pulmonary arterial hypertension is particularly common in individuals with systemic sclerosis, but is also seen in other rheumatic diseases. A number of treatment optionsfor this serious complication are available, including selective and unselective endothelin-receptor antagonists, which are the subject of this review.
引用
收藏
页码：93 / 101
页数：8
相关论文
共 50 条
  • [21] Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
    O'Callaghan, Dermot S.
    Savale, Laurent
    Yaici, Azzedine
    Natali, Delphine
    Jais, Xavier
    Parent, Florence
    Montani, David
    Humbert, Marc
    Simonneau, Gerald
    Sitbon, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (10) : 1585 - 1596
  • [22] Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension
    Langleben, David
    CLINICS IN CHEST MEDICINE, 2007, 28 (01) : 117 - +
  • [23] Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview
    Raja, Shahzad G.
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) : e65 - e71
  • [24] Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis (vol 59, pg 8168, 2016)
    Aubert, John-David
    Juillerat-Jeanneret, Lucienne
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (04) : 1617 - 1617
  • [25] Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
    Venitz, Juergen
    Zack, Julia
    Gillies, Hunter
    Allard, Martine
    Regnault, Jean
    Dufton, Christopher
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (12): : 1784 - 1805
  • [26] Endothelin and endothelin receptor antagonists in systemic rheumatic disease
    Mayes, MD
    ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1190 - 1199
  • [27] Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008
    Cacoub, P.
    Amoura, Z.
    Langleben, D.
    REVUE DE MEDECINE INTERNE, 2008, 29 (04): : 283 - 289
  • [28] Role of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension
    Abman, Steven H.
    ANNUAL REVIEW OF MEDICINE, 2009, 60 : 13 - 23
  • [29] The future of endothelin-receptor antagonism as treatment for systemic hypertension
    Vorobiof, Gabriel
    Blaxall, Burns C.
    Bisognano, John D.
    CURRENT HYPERTENSION REPORTS, 2006, 8 (01) : 35 - 44
  • [30] The future of endothelin-receptor antagonism as treatment for systemic hypertension
    Gabriel Vorobiof
    Burns C. Blaxall
    John D. Bisognano
    Current Hypertension Reports, 2006, 8 : 35 - 44
12345